Myriad Genetics MYGN Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$365.9M-187% | -$127.3M+51.7% | -$263.3M-135% | -$112M-312% | ||
| $53.7M-12.3% | $61.2M-1.1% | $61.9M+17.5% | $52.7M-16.1% | ||
| $35.2M-29.3% | $49.8M+22.4% | $40.7M+6.8% | $38.1M+5.0% | ||
| $1.8M— | —— | -$110.9M-4.3% | -$106.3M— | ||
| -$27.4M— | —— | —— | —— | ||
| —— | $120M+50.0% | $80M— | —— | ||
| —— | $119.5M+199% | $40M— | $0-100% | ||
| —— | —— | $155.4M— | —— | ||
| $42.9M— | —— | —— | -$196.9M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Myriad Genetics generate?
- Myriad Genetics (MYGN) generated $2.4M in operating cash flow over the trailing twelve months.
- Where does Myriad Genetics's cash flow data come from?
- Every line is extracted from Myriad Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
